Page last updated: 2024-11-08
hemoglobin randwick
Description
hemoglobin Randwick: unstable beta chain hemoglobin variant; Try replaced by Gly on beta chain 15(A12) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
(1->4)-beta-D-mannan : A mannan composed from D-mannan residues joined by beta-(1->4) linkages. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
beta-D-mannose : A D-mannopyranose in which the anomeric centre has beta-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
(1->2)-beta-D-mannan : A mannan consisting of repeating mannosyl units joined via beta-(1->2)-linkages. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
Synonyms (34)
Synonym |
beta-d-mannopyranose |
CHEBI:28563 , |
7322-31-8 |
beta-d-mannose |
C02209 |
[2)-beta-d-manp-(1->]n |
(1->2)-beta-d-mannan |
(1->2)-beta-d-mannopyranan |
CHEBI:59573 |
(2r,3s,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol |
100919-15-1 |
beta-1,4-mannan |
unii-cuo87o37mt |
beta-mannose |
cuo87o37mt , |
116874-33-0 |
hemoglobin randwick |
EPITOPE ID:137485 |
.beta.-d-mannose |
.beta.-d-mannopyranose |
WQZGKKKJIJFFOK-RWOPYEJCSA-N |
CHEBI:80962 |
SCHEMBL396651 |
CHEBI:27857 |
(1->4)-beta-d-mannan |
102208-02-6 |
beta-d-mannose; d-mannose; mannose |
Q27103775 |
(2r,3s,4s,5s,6r)-6-(hydroxymethyl)tetrahydro-2h-pyran-2,3,4,5-tetraol |
DTXSID501015877 , |
EN300-105842 |
adenosine 5/'-diphosphomannose, disodium salt |
wurcs=2.0/1,1,0/(a1122h-1b_1-5)/1/ |
dtxcid101474031 |
Roles (1)
Role | Description |
epitope | The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (1)
Class | Description |
D-mannopyranose | D-Mannose in its six-membered ring form. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (12)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.28
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.28 (24.57) | Research Supply Index | 2.56 (2.92) | Research Growth Index | 4.85 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (8.33%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (91.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |